MYC and hepatocellular carcinoma: Sustained activation of c-Myc and AP-1 disrupts regulatory networks, enhancing oncogenic transformation, apoptosis resistance, and genomic instability, thus accelerating HCC progression (Vishnoi et al., 2020).